Postpartum BP Trajectory May Predict Persistent Hypertension
MONDAY, Feb. 8, 2021 -- Blood pressure (BP) trajectories in the first six weeks postpartum may help identify women who are likely to have persistent hypertension at six to 18 months, according to a study presented at The Pregnancy Meeting, the annual meeting of the Society for Maternal-Fetal Medicine, held virtually from Jan 25 to 30.
Eesha Dave, M.D., from the UPMC Magee-Womens Hospital in Pittsburgh, and colleagues evaluated BP trajectories in the first six weeks postpartum among 368 women with hypertensive disorders of pregnancy (HDP; February 2018 through June 2019) participating in a remote postpartum hypertension monitoring program (5,958 BP measurements; mean follow-up, 12.9 months postpartum).
The researchers found that 49.5 percent of women were hypertensive at follow-up and 50.5 percent were normotensive. Prepregnancy body mass index (pBMI) was higher among women who were hypertensive at follow-up. Women with persistent hypertension had a slower decline in BP in the first six weeks postpartum and had higher BPs at the postpartum visit, despite no differences in BP at the first prenatal visit. When adjusting for pBMI and type of HDP, these differences persisted.
"By leveraging data from our widely scaled postpartum hypertension remote monitoring program, we were able to discover that a woman's blood pressure in the first six weeks after childbirth appears to be an important indicator of whether she is likely to develop chronic hypertension six to 18 months later," Dave said in a statement.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
THURSDAY, Feb. 25, 2021 -- Low disease activity and remission are feasible goals for women with rheumatoid arthritis (RA) cared for with a modern treatment approach during...
WEDNESDAY, Feb. 24, 2021 -- The U.S. Preventive Services Task Force (USPSTF) recommends the use of low-dose aspirin as preventive medication after 12 weeks of gestation for...
TUESDAY, Feb. 23, 2021 -- Children conceived by assisted reproduction technology (ART) are shorter and lighter at birth than those conceived naturally, but have similar height and...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.